These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7907073)

  • 1. Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C.
    Jouët P; Roudot-Thoraval F; Dhumeaux D; Métreau JM
    Gastroenterology; 1994 Mar; 106(3):686-90. PubMed ID: 7907073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
    Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
    Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of high initial and fixed-dose regimens of interferon-alpha2a in chronic hepatitis C: a randomized controlled trial. French Multicenter Interferon Study Group.
    Ouzan D; Babany G; Valla D; Opolon P
    J Viral Hepat; 1998 Jan; 5(1):53-9. PubMed ID: 9493517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment.
    Métreau JM
    Gut; 1993; 34(2 Suppl):S112-3. PubMed ID: 8314474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.
    Camps J; Crisóstomo S; García-Granero M; Riezu-Boj JI; Civeira MP; Prieto J
    Gut; 1993 Dec; 34(12):1714-7. PubMed ID: 7904252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis C with a-interferon: an analysis of the literature.
    Niederau C; Heintges T; Häussinger D
    Hepatogastroenterology; 1996; 43(12):1544-56. PubMed ID: 8975964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response.
    Mazzella G; Salzetta A; Casanova S; Morelli MC; Villanova N; Miniero R; Sottili S; Novelli V; Cipolla A; Festi D
    Dig Dis Sci; 1994 Apr; 39(4):866-70. PubMed ID: 7908624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.
    Lai MY; Kao JH; Yang PM; Wang JT; Chen PJ; Chan KW; Chu JS; Chen DS
    Gastroenterology; 1996 Nov; 111(5):1307-12. PubMed ID: 8898645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of chronic hepatitis C with alpha-interferon in 182 patients. Evaluation of results, response predictive factors and side effects].
    Marelli A; Nardecchia L; De Gennaro F; Reggiani A; Quinzani M; Bodini P
    Minerva Med; 1999; 90(11-12):405-12. PubMed ID: 10829802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
    Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
    Lindsay KL; Davis GL; Schiff ER; Bodenheimer HC; Balart LA; Dienstag JL; Perrillo RP; Tamburro CH; Goff JS; Everson GT; Silva M; Katkov WN; Goodman Z; Lau JY; Maertens G; Gogate J; Sanghvi B; Albrecht J
    Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment].
    Pérez Roldán F; De Diego A; Casado M; Matilla A; Bañares R; García-Durán F; Salcedo M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1996 Sep; 88(9):609-15. PubMed ID: 8962775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of hepatitis C: interferon alfa-n1 trials.
    Farrell GC
    Hepatology; 1997 Sep; 26(3 Suppl 1):96S-100S. PubMed ID: 9305672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.
    Causse X; Godinot H; Chevallier M; Chossegros P; Zoulim F; Ouzan D; Heyraud JP; Fontanges T; Albrecht J; Meschievitz C
    Gastroenterology; 1991 Aug; 101(2):497-502. PubMed ID: 1906028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human interferon alpha-2a therapy for chronic hepatitis C with or without cirrhosis: comparison of 3 or 6 MU for 1 year.
    Caporaso N; Suozzo R; Morisco F; D'Antonio M; Romano M; Coltorti M
    Ital J Gastroenterol; 1993; 25(9):482-6. PubMed ID: 8123895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C: limits and dose regimen of interferon alfa.
    Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.
    Pawlotsky JM; Roudot-Thoraval F; Bastie A; Darthuy F; Rémiré J; Métreau JM; Zafrani ES; Duval J; Dhumeaux D
    J Infect Dis; 1996 Jul; 174(1):1-7. PubMed ID: 8655978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Interferon retreatment of patients with chronic hepatitis C.
    Rabinovitz M; Block G; Finkelstein SD
    Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
    Poynard T; Bedossa P; Chevallier M; Mathurin P; Lemonnier C; Trepo C; Couzigou P; Payen JL; Sajus M; Costa JM
    N Engl J Med; 1995 Jun; 332(22):1457-62. PubMed ID: 7739681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity.
    Serfaty L; Chazouillères O; Pawlotsky JM; Andreani T; Pellet C; Poupon R
    Gastroenterology; 1996 Jan; 110(1):291-5. PubMed ID: 8536870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.